Cite
Monitoring the dynamics of clinical and laboratory markers of chronic heart failure during 12 months of sacubitril/valsartan treatment.
MLA
Čepelová, Jana, et al. “Monitoring the Dynamics of Clinical and Laboratory Markers of Chronic Heart Failure during 12 Months of Sacubitril/Valsartan Treatment.” Vnitrni Lekarstvi, vol. 67, no. 4, Summer 2021, pp. 212–17. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=34275306&authtype=sso&custid=ns315887.
APA
Čepelová, J., Malý, M., Daněk, J., & Malý, M. (2021). Monitoring the dynamics of clinical and laboratory markers of chronic heart failure during 12 months of sacubitril/valsartan treatment. Vnitrni Lekarstvi, 67(4), 212–217.
Chicago
Čepelová, Jana, Marek Malý, Josef Daněk, and Martin Malý. 2021. “Monitoring the Dynamics of Clinical and Laboratory Markers of Chronic Heart Failure during 12 Months of Sacubitril/Valsartan Treatment.” Vnitrni Lekarstvi 67 (4): 212–17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=34275306&authtype=sso&custid=ns315887.